DEEP SEQUENCING ANALYSES IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN THE COSMOS STUDY

被引:0
|
作者
Fevery, B. [1 ]
Thys, K. [1 ]
Van Rossem, E. [1 ]
Verbinnen, T. [1 ]
Picchio, G. [2 ]
Aerssens, J. [1 ]
De Meyer, S. [1 ]
Beumont, M. [1 ]
Kurland, D. [2 ]
Lenz, O. [1 ]
机构
[1] Janssen Infect Dis BVBA, Beerse, Belgium
[2] Janssen Res & Dev LLC, Titusville, NJ USA
关键词
D O I
10.1016/S0168-8278(15)30983-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P0780
引用
收藏
页码:S623 / S623
页数:1
相关论文
共 50 条
  • [1] DEEP SEQUENCING ANALYSES OF MINORITY BASELINE POLYMORPHISMS AND PERSISTENCE OF EMERGING MUTATIONS IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH SIMEPREVIR
    Fevery, B.
    Thys, K.
    Van Eygen, V.
    Verbinnen, T.
    Van Rossem, E.
    Picchio, G.
    De Meyer, S.
    Lenz, O.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S139 - S139
  • [2] Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies
    Lenz, Oliver
    Verbinnen, Thierry
    Fevery, Bart
    Tambuyzer, Lotke
    Vijgen, Leen
    Peeters, Monika
    Buelens, Annemie
    Ceulemans, Hugo
    Beumont, Maria
    Picchio, Gaston
    De Meyer, Sandra
    JOURNAL OF HEPATOLOGY, 2015, 62 (05) : 1008 - 1014
  • [3] Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection
    Sulkowski, Mark S.
    Vargas, Hugo E.
    Di Bisceglie, Adrian M.
    Kuo, Alexander
    Reddy, K. Rajender
    Lim, Joseph K.
    Morelli, Giuseppe
    Darling, Jama M.
    Feld, Jordan J.
    Brown, Robert S.
    Frazier, Lynn M.
    Stewart, Thomas G.
    Fried, Michael W.
    Nelson, David R.
    Jacobson, Ira M.
    GASTROENTEROLOGY, 2016, 150 (02) : 419 - 429
  • [4] Simeprevir plus peginterferon/ribavirin for HCV genotype 1-infected treatment-naive patients in China and South Korea
    Wei, Lai
    Han, Tao
    Yang, Dongliang
    Heo, Jeong
    Shang, Jia
    Cheng, Jun
    Chen, Xinyue
    Xie, Qing
    Kim, Ju-Hyun
    Kalmeijer, Ronald
    Ouwerkerk-Mahadevan, Sivi
    Hoeben, Eva
    Lenz, Oliver
    Verbinnen, Thierry
    Sinha, Rekha
    Li, MengChun
    Scott, Jane
    Peeters, Monika
    Witek, James
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (05) : 912 - 920
  • [5] Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845
    Vijgen, Leen
    Thys, Kim
    Vandebosch, An
    Van Remoortere, Pieter
    Verloes, Rene
    De Meyer, Sandra
    VIROLOGY JOURNAL, 2017, 14
  • [6] Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845
    Leen Vijgen
    Kim Thys
    An Vandebosch
    Pieter Van Remoortere
    René Verloes
    Sandra De Meyer
    Virology Journal, 14
  • [7] Simeprevir versus telaprevir in combination with pegylated interferon and ribavirin in HCV genotype 1-infected patients: the Phase III ATTAIN study
    Hinrichsen, H.
    Reddy, K.
    Zoulim, F.
    Weiland, O.
    Horban, A.
    Taliani, G.
    Stanciu, C.
    Villamil, F.
    George, J.
    Dammers, E.
    Fu, M.
    Kurland, D.
    Lenz, O.
    Ouwerkek-Mahadevan, S.
    Verbinnen, T.
    Schlag, M.
    Jessner, W.
    Zeuzem, S.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 : 6 - 7
  • [8] Comparison of simeprevir plus peginterferon/ribavirin and telaprevir plus peginterferon/ribavirin for patients with HCV Genotype 1
    Nakajima, Tomoaki
    Kimura, Mutuumi
    Arakawa, Tomohiro
    Kuwata, Yasuaki
    Ozeki, Itaru
    Sato, Takahiro
    Ohmura, Takumi
    Hige, Shuhei
    Karino, Yoshiyasu
    Toyota, Joji
    HEPATOLOGY, 2013, 58 : 1140A - 1141A
  • [9] Simeprevir in HCV genotype-1-infected patients: deep sequencing analyses of the PILLAR and ASPIRE Phase IIb trials
    Lenz, O.
    Fevery, B.
    Thys, K.
    Van Eygen, V.
    Aerssens, J.
    Reumers, J.
    Peeters, M.
    Verbinnen, T.
    Beumont-Mauviel, M.
    Picchio, G.
    ANTIVIRAL THERAPY, 2013, 18 : A14 - A14
  • [10] Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis
    Modi, Apurva A.
    Nazario, Hector
    Trotter, James F.
    Gautam, Manjushree
    Weinstein, Jeffrey
    Mantry, Parvez
    Barnes, Maisha
    Habib, Adil
    McAfee, Jean
    Teachenor, Olga
    Tujague, Lauren
    Gonzalez, Stevan
    LIVER TRANSPLANTATION, 2016, 22 (03) : 281 - 286